|
| 38064128 | Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center. | Clin Exp Metastasis | 2024 |
| 36890834 | Flavin fluorescence lifetime and autofluorescence optical redox ratio for improved visualization and classification of brain tumors. | Front Oncol | 2023 |
| 38024240 | Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma. | Neurooncol Adv | 2023 |
| 37919354 | Multi-class glioma segmentation on real-world data with missing MRI sequences: comparison of three deep learning algorithms. | Sci Rep | 2023 |
| 37919325 | Segmentation of glioblastomas in early post-operative multi-modal MRI with deep neural networks. | Sci Rep | 2023 |
| 37543970 | Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis. | J Neurooncol | 2023 |
| 37219741 | Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer. | Clin Exp Metastasis | 2023 |
| 37390078 | Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment. | PLoS One | 2023 |
| 36947280 | Brain metastases from hepatopancreatobiliary malignancies. | Clin Exp Metastasis | 2023 |
| 37345077 | Evaluation of Gliomas with Magnetic Resonance Fingerprinting with PET Correlation-A Comparative Study. | Cancers (Basel) | 2023 |
| 37036472 | Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer. | Clin Cancer Res | 2023 |
| 37202469 | Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts. | NPJ Precis Oncol | 2023 |
| 36959422 | Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging. | Nat Med | 2023 |
| 36924489 | 102â¿¿AI-Based Molecular Classification of Diffuse Gliomas using Rapid, Label-Free Optical Imaging. | Neurosurgery | 2023 |
| 36816966 | Sex-specific radiomic features of L-[S-methyl-<sup>11</sup>C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability. | Front Oncol | 2023 |
| 36740985 | A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors. | EMBO Mol Med | 2023 |
| 34342680 | Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature. | J Neurol | 2022 |
| 35430323 | Does pigmentation, hemosiderin and blood effect visible 5-ALA fluorescence in cerebral melanoma metastasis? | Photodiagnosis Photodyn Ther | 2022 |
| 35665365 | Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas. | Front Med (Lausanne) | 2022 |
| 35565293 | 7T HR FID-MRSI Compared to Amino Acid PET: Glutamine and Glycine as Promising Biomarkers in Brain Tumors. | Cancers (Basel) | 2022 |
| 35590389 | Prediction of glioma-subtypes: comparison of performance on a DL classifier using bounding box areas versus annotated tumors. | BMC Biomed Eng | 2022 |
| 36455278 | Toward digital histopathological assessment in surgery for central nervous system tumors using stimulated Raman histology. | Neurosurg Focus | 2022 |
| 35941372 | Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial. | Nat Med | 2022 |
| 35998208 | Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns. | Clin Cancer Res | 2022 |
| 35968292 | Preoperative Brain Tumor Imaging: Models and Software for Segmentation and Standardized Reporting. | Front Neurol | 2022 |
| 36009108 | The NXDC-MEN-301 Study on 5-ALA for Meningiomas Surgery: An Innovative Study Design for the Assessing the Benefit of Intra-Operative Fluorescence Imaging. | Brain Sci | 2022 |
| 36187350 | The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers. | Front Mol Neurosci | 2022 |
| 36115057 | CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers. | J Neurosurg | 2022 |
| 35158990 | MR Fingerprinting-A Radiogenomic Marker for Diffuse Gliomas. | Cancers (Basel) | 2022 |
| 35149260 | Analysis of corticosteroid and antiepileptic drug treatment effects on heme biosynthesis mRNA expression in lower-grade gliomas: Potential implications for 5-ALA metabolization. | Photodiagnosis Photodyn Ther | 2022 |
| 35213082 | Prognostic impact of genetic alterations and methylation classes in meningioma. | Brain Pathol | 2022 |
| 35145254 | Correction: Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. | Br J Cancer | 2022 |
| 34998049 | Changing characteristics, treatment approaches and survival of patients with brain metastasis: data from six thousand and thirty-one individuals over an observation period of 30 years. | Eur J Cancer | 2022 |
| 35326730 | MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy. | Cancers (Basel) | 2022 |
| 35229396 | Enhanced expression of autophagy-related p62 without increased deposits of neurodegeneration-associated proteins in glioblastoma and surrounding tissue - An autopsy-based study. | Brain Pathol | 2022 |
| 34515312 | Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas. | Neuro Oncol | 2022 |
| 34687073 | QSMxT: Robust masking and artifact reduction for quantitative susceptibility mapping. | Magn Reson Med | 2022 |
| 32608510 | High Diagnostic Accuracy of Visible 5-ALA Fluorescence in Meningioma Surgery According to Histopathological Analysis of Tumor Bulk and Peritumoral Tissue. | Lasers Surg Med | 2021 |
| 33546427 | Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases. | Cancers (Basel) | 2021 |
| 33651248 | LAG-3 expression in the inflammatory microenvironment of glioma. | J Neurooncol | 2021 |
| 33540564 | Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma. | Cancers (Basel) | 2021 |
| 33588158 | Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases. | ESMO Open | 2021 |
| 33562253 | Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas. | Cancers (Basel) | 2021 |
| 34891851 | High-Resolution Magnetic Resonance Spectroscopic Imaging using a Multi-Encoder Attention U-Net with Structural and Adversarial Loss. | Annu Int Conf IEEE Eng Med Biol Soc | 2021 |
| 34885227 | Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years. | Cancers (Basel) | 2021 |
| 34572900 | Glioblastoma Surgery Imaging-Reporting and Data System: Validation and Performance of the Automated Segmentation Task. | Cancers (Basel) | 2021 |
| 34395266 | 5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches. | Front Oncol | 2021 |
| 34595120 | Fluorescence Lifetime Imaging and Spectroscopic Co-Validation for Protoporphyrin IX-Guided Tumor Visualization in Neurosurgery. | Front Oncol | 2021 |
| 34678775 | Influence of dexamethasone on visible 5-ALA fluorescence and quantitative protoporphyrin IX accumulation measured by fluorescence lifetime imaging in glioblastomas: is pretreatment obligatory before fluorescence-guided surgery? | J Neurosurg | 2021 |
| 34830859 | Reply to Stummer, W.; Thomas, C. Comment on "Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540". | Cancers (Basel) | 2021 |